BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

459 related articles for article (PubMed ID: 15068488)

  • 1. The osteoporosis care gap in Canada.
    Papaioannou A; Giangregorio L; Kvern B; Boulos P; Ioannidis G; Adachi JD
    BMC Musculoskelet Disord; 2004 Apr; 5():11. PubMed ID: 15068488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragility fractures and the osteoporosis care gap: an international phenomenon.
    Giangregorio L; Papaioannou A; Cranney A; Zytaruk N; Adachi JD
    Semin Arthritis Rheum; 2006 Apr; 35(5):293-305. PubMed ID: 16616152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physician practices of bone density testing and drug prescribing to prevent or treat osteoporosis during androgen deprivation therapy.
    Tanvetyanon T
    Cancer; 2005 Jan; 103(2):237-41. PubMed ID: 15597384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.
    CMAJ; 1996 Oct; 155(8):1113-33. PubMed ID: 8873639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation and treatment of osteoporosis in patients with fragility fractures.
    Hajcsar EE; Hawker G; Bogoch ER
    CMAJ; 2000 Oct; 163(7):819-22. PubMed ID: 11033708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Underdiagnosis and under-treatment of osteoporosis following fragility fracture.
    Aboyoussef M; Vierkoetter KR
    Hawaii Med J; 2007 Jul; 66(7):185-7. PubMed ID: 17879856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture.
    Seeman E; Eisman JA
    Med J Aust; 2004 Mar; 180(6):298-303. PubMed ID: 15012571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoporosis disease management for fragility fracture patients: new understandings based on three years' experience with an osteoporosis care service.
    Harrington JT; Lease J
    Arthritis Rheum; 2007 Dec; 57(8):1502-6. PubMed ID: 18050169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteodensitometry in healthy postmenopausal women.
    Prescrire Int; 2008 Apr; 17(94):68-72. PubMed ID: 18536138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and therapy of osteoporosis. Strategy for effective treatment after fragility fractures].
    Bartl R; Bartl C; Mutschler W
    Unfallchirurg; 2003 Jul; 106(7):526-41. PubMed ID: 12883779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prevention of osteoporosis: Calcium, Vitamin D and bisphosphonate prescribing following distal radial fracture.
    Talbot JC; Elener C; Praveen P; Shaw DL
    Injury; 2007 Nov; 38(11):1236-40. PubMed ID: 17572417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis pharmacotherapy and counseling services in US ambulatory care clinics: opportunities for multidisciplinary interventions.
    Teschemaker A; Lee E; Xue Z; Wutoh AK
    Am J Geriatr Pharmacother; 2008 Dec; 6(5):240-8. PubMed ID: 19161926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of osteoporotic fractures in the elderly.
    Wilkins CH; Birge SJ
    Am J Med; 2005 Nov; 118(11):1190-5. PubMed ID: 16271899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hip fracture patients are not treated for osteoporosis: a call to action.
    Harrington JT; Broy SB; Derosa AM; Licata AA; Shewmon DA
    Arthritis Rheum; 2002 Dec; 47(6):651-4. PubMed ID: 12522840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoporosis management: physicians' recommendations and womens' compliance following osteoporosis testing.
    Cole RP; Palushock S; Haboubi A
    Women Health; 1999; 29(1):101-15. PubMed ID: 10427644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis and upper extremity fragility fractures.
    Foote JE; Rozental TD
    J Hand Surg Am; 2012 Jan; 37(1):165-7. PubMed ID: 22037301
    [No Abstract]   [Full Text] [Related]  

  • 17. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of a strategy for the management of accompanying osteoporosis after inpatient treatment of fragility fractures].
    Bahrs C; Türk A; Eingartner C; Weise K; Rolauffs B; Stuby F
    Z Orthop Unfall; 2008; 146(1):52-8. PubMed ID: 18324582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis and pharmacologic therapy of osteoporosis].
    Lakatos P
    Orv Hetil; 2003 Jul; 144(28):1373-9. PubMed ID: 12914121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osteoporosis: evaluation and treatment.
    Bajaj S; Saag KG
    Curr Womens Health Rep; 2003 Oct; 3(5):418-24. PubMed ID: 12959702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.